Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It will be interesting to see how PTSC can impact TPL

Which company doesn't expect to issue stock for equity based financings, and of these how many have to seek shareholder approval before doing so, and under what circumstances?

What are your motives?

.

.

.

Be well

Share
New Message
Please login to post a reply